# Ikena Oncology

Source: https://onco.cc/companies/ikena-oncology/  
OnCo record `ikena-oncology` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Ikena Oncology developed targeted cancer drugs. In July 2025 it merged with Inmagene Biopharmaceuticals and renamed itself ImageneBio, which now works on an antibody for eczema rather than cancer.

## Summary

Ikena Oncology described itself as developing therapies that target nodes of cancer growth, spread and treatment resistance, and was listed on Nasdaq as IKNA. On 23 December 2024 it agreed to merge with Inmagene Biopharmaceuticals with a $75 million private placement whose syndicate included existing Ikena investors BVF Partners, Blue Owl, Omega Funds and OrbiMed. The merger completed on 25 July 2025, when Ikena changed its name to ImageneBio, Inc.; the combined company, based in San Diego, focuses on olevaprubart, an anti-OX40 antibody for atopic dermatitis, so the business no longer works on cancer.

## Fields

- Kind: Company
- Last checked: 2026-11-04
- Also known as: Ikena Oncology, Inc.; ImageneBio, Inc.
- HQ: Boston, MA
- Type: biotech

## Notes

- Atlas's portfolio text says 'Merged with Inmagene (2024)'; the agreement was signed in December 2024 and the merger closed on 25 July 2025 (SEC 8-K).
- Recorded as acquired because the oncology business ended in a merger; strictly, Ikena's listed entity survived and was renamed ImageneBio. ImageneBio is not oncology and should not get its own record.
- ikenaoncology.com now redirects to imagenebio.com, so no website is set.
- Ikena's named oncology programmes were not in the sources read; none recorded.

## Sources

- Ikena and Inmagene merger agreement (SEC exhibit, 23 December 2024): https://www.sec.gov/Archives/edgar/data/1835579/000119312524283722/d889670dex991.htm
- Merger completed and name change (SEC 8-K, 25 July 2025): https://www.sec.gov/Archives/edgar/data/1835579/000119312525167089/d66290d8k.htm
- ImageneBio website: https://imagenebio.com/
- Atlas Venture portfolio entry: https://atlasventure.com/portfolio/

## Connected records

- fronts: [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- companies: [Atlas Venture](https://onco.cc/companies/atlas-venture/), [Omega Funds](https://onco.cc/companies/omega-funds/), [OrbiMed](https://onco.cc/companies/orbimed/)

---
JSON: https://onco.cc/api/v1/entities/ikena-oncology.json